DRUG PRECAUTIONARY PRINCIPLE is alive and well at the FDA and other drug regulatory agencies worldwide. The proponent of a new product undertakes the cost and responsibility of proving, to an objective statistical criterion, that the drug is both safe and effective. Obviously, safety is tempered by cost-benefit analysis, but efficacy (read “need” here) is held to the highest standards.
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022